ATTR-CM Scores Get Mixed Results for Flagging Risk in Diverse Patients

(MedPage Today) — Scoring tools validated to identify people at high risk of having transthyretin amyloid cardiomyopathy (ATTR-CM) still leave room for improvement in diverse populations.
The ATTR-CM score and the T-Amylo score have been validated…